Patents by Inventor Wan PANG

Wan PANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260086142
    Abstract: The present disclosure relates to a field of semiconductor technology, and in particular to a method and apparatus of predicting an endurance of a chip, a computer-readable medium, and an electronic device. The method includes: building a dataset according to endurance test data of a target chip, where the dataset includes a training set and a test set; acquiring a machine learning model, and training the machine learning model through the training set; and predicting an endurance of the target chip through the machine learning model.
    Type: Application
    Filed: May 17, 2023
    Publication date: March 26, 2026
    Inventors: Xiaoxin XU, Xu ZHENG, Lizhou WU, Xiaoyong XUE, Wan PANG
  • Patent number: 11279678
    Abstract: Disclosed is a 5-fluorouracil derivative having the molecular structure shown in general formula VI, in which Ra and Rb groups are an alkoxy group or a fluorine-substituted alkoxy group having 1, 2, 3, or 4 carbon atoms, and are mono-, bis-, tri-, tetra- or penta-substituted on a phenyl group; a linking group L1 is an alkyl or alkenyl group having 1, 2, 3, or 4 carbon atoms, a linking group L2 is oxygen, or an alkyl or alkoxy group having 1, 2, 3, or 4 carbon atoms, or an amino acid, or an alkyl group having 1, 2, 3, or 4 carbon atoms containing an amino moiety, or a furyl group, and an X group is O or —NH—. Further disclosed is a method for preparing such a derivative and a use of the same in the treatment of cancer, tumor diseases, and diseases caused by abnormal neovascularization in a human or non-human mammal, and a medicament or a composition containing the 5-fluorouracil derivative.
    Type: Grant
    Filed: November 9, 2017
    Date of Patent: March 22, 2022
    Inventors: Fanhong Wu, Jinwen Huang, Jiujiu Zhou, Wan Pang, Lei Zhao, Zhonglin Ma, Zhikai Zhang, Xiaodong Yu, Jianyue Wu
  • Publication number: 20210230122
    Abstract: Disclosed is a 5-fluorouracil derivative having the molecular structure shown in general formula VI, in which Ra and Rb groups are an alkoxy group or a fluorine-substituted alkoxy group having 1, 2, 3, or 4 carbon atoms, and are mono-, bis-, tri-, tetra- or penta-substituted on a phenyl group; a linking group L1 is an alkyl or alkenyl group having 1, 2, 3, or 4 carbon atoms, a linking group L2 is oxygen, or an alkyl or alkoxy group having 1, 2, 3, or 4 carbon atoms, or an amino acid, or an alkyl group having 1, 2, 3, or 4 carbon atoms containing an amino moiety, or a furyl group, and an X group is O or —NH—. Further disclosed is a method for preparing such a derivative and a use of the same in the treatment of cancer, tumor diseases, and diseases caused by abnormal neovascularization in a human or non-human mammal, and a medicament or a composition containing the 5-fluorouracil derivative.
    Type: Application
    Filed: November 9, 2017
    Publication date: July 29, 2021
    Inventors: Fanhong WU, Jinwen HUANG, Jiujiu ZHOU, Wan PANG, Lei ZHAO, Zhonglin MA, Zhikai ZHANG, Xiaodong YU, Jianyue WU